跳到正文

全部动态

今日 64 条
10月12日周一
  1. A股药企公告(东财)8

    药明康德发布H股公告

    药明康德发布H股公告,相关数据来自东方财富Choice数据。东方财富网声明该信息仅用于传播更多信息,与本站立场无关,不保证其准确性、真实性、完整性、有效性、及时性、原创性等,且不构成任何投资建议。

  2. 梅斯医学 MedSci10

    专访GW-ICC/AHS.26大会理事长唐熠达:立足临床、交叉融合,推动亚洲心血管协同发展

    第37届长城心脏病学大会暨亚洲心脏大会2026(GW-ICC/AHS.26)将于2026年10月15日至18日在北京召开,大会理事长、北京大学第三医院唐熠达教授在会前专访中表示,本届大会以"立足临床,交叉融合"为主题,坚持面向真实临床需求。唐熠达强调心血管代谢综合管理需从单病线性诊疗转向覆盖血压、血糖、血脂、肥胖、高尿酸的网状思维与全程管理,并指出AI现阶段仍是辅助工具,不应高估其独立诊疗能力。

  3. 梅斯医学 MedSci8

    2026脑机接口前沿技术与产业转化大会10月16日上海启幕,13位嘉宾覆盖BCI技术全版图

    2026脑机接口前沿技术与产业转化大会将于10月16日-17日在上海虹桥金沙voco酒店举行,主题为"突破·转化·共生——脑机接口从实验室到临床到产业"。大会由生物谷、长三角物理研究中心、复旦大学神经调控与脑机接口研究中心主办,设单会场及Poster展示区与展位区,规模300-500人,13位确认嘉宾来自10所顶尖机构。

  4. 梅斯医学 MedSci30

    医生陪同做检查反被投诉拉断患者胳膊,四川一地卫健局明确恶意投诉不纳入核查范围

    湖北一医生好心陪同77岁骨折患者做核磁共振检查,出院后家属打12345投诉称医生拉断患者右上肢,要求全免治疗费用,而实际情况是家属搀扶老人上厕所时滑倒骨折。针对此类恶意投诉,四川一地卫健局明确建立医疗类诉求前置审核甄别机制,对无实质违规的投诉不纳入正式核查范围,坚决落实"无过错不追责、无过错不致歉"原则。

10月11日周日
  1. Eric Topol22

    而今天,反过来看,如果通过禁令把AI从医生手中拿走,会发生什么 @NEJM https://www.nejm.org/doi/full/10.1056/NEJMp2609409?query=WB

    引用Eric Topol@EricTopol

    AI is changing medical practice, as @RBMD1982 points out @nytopinion But there are certainly concerns regarding deskilling and never-skilling among younger physicians, trainees, and students (w/@AdamRodmanMD) "Now, the chatbot in my pocket reassures me that I will always know enough, or have access to the cloud-based intelligence that generally does." https://www.nytimes.com/2026/09/25/opinion/ai-doctor-medical-students.html?unlocked_article_code=1.D1E.cnaZ.KYfHzhXh4yhc&smid=url-share

10月10日周六
  1. Adam Feuerstein ✡️22

    Adam Feuerstein 认同 Peter Kolchinsky 的观点:市场应朝推出相对低价、低剂量的非处方 GLP-1 方向发展,用于减重或体重增加预防。

    引用Peter Kolchinsky@PeterKolchinsky

    I think the biggest market pharma will ever tackle will actually be weight gain PREVENTION. And the dynamics of this market are going to be very different from the medicalized weight loss market and require better, more convenient products. The race for that market has only just begun. We helped to pivot one of our companies, Terrestrial, to work in prevention (as well as weight loss), and their clinical progress now makes me comfortable sharing our thesis for the weight gain prevention space. They have a needle-free, room-temp stable microneedle patch where the microneedles are made of semaglutide. Apply it for a few min, the base of the needles dissolves leaving drug under the skin, and you can then throw away the patch. That’s the weekly dose. No sharps containers. Once drug is under skin, it behaves very similarly to regularly injected semaglutide. 505b2 path to market is derisked by all existing data on sema. But Terrestrial isn’t stopping at just getting approved for all same indications as sema. It’s also gunning to get it OTC and get weight gain prevention on the label, legitimizing what today is a common off-label use (so common that South Park parodied it). From a societal value, there may not be any single medical breakthrough that rivals what a needle-free, OTC QW GLP-1 can offer to humanity. Excess weight leads to so much disability, disease, cost, lost productivity, and early mortality. Doesn’t make sense for people to have to gain weight to then get help losing it. Makes more sense for them to get help quieting the hunger noise (drive to eat) so they can avoid gaining weight in the first place. Have doubts? No problem. Read the article and then decide. The key insight here is that an OTC needle-free GLP-1 is not simply some late comer to a mature category but actually the beginning of an entirely new market that is so large that it would be worth any consumer-focused company to pay attention and for any standard pharma to consider what it would take to pivot into this space. And if you have never experienced how a GLP-1 can quiet hunger noise, you’ll have a harder time relating. Young people with fast metabolisms will likely miss this. But someday they will say “holy crap, I get it!”. 60% of Americans are overweight or obese… the battle against weight gain is one most people are destined to lose without help. 3B people around the world are overweight/obese. This is a giant global market at even very low unit prices (eg $25/month). Enjoy the read. Godspeed Terrestial! The RA Capital team is really proud to support you.

  2. 梅斯医学 MedSci22

    夜班医生打盹被定性为"不良事件"引争议:国家卫健委定义被指泛化,疲劳行医风险几何?

    一名夜班医生处理完所有患者后在值班室短暂小憩被患者投诉,医院决定不处罚但将其作为不良事件上报。文章指出,国家卫健委2018年《医疗质量安全核心制度要点》允许值班人员在指定地点休息,而2024年国卫办医政函〔2024〕272号对不良事件的定义要求存在不安全隐患或负性后果,此次零延误、零差错的待命休息被定性为不良事件属于定义泛化。